"The Sontag Foundation Award was a 'game changer'." It represented the first instance of substantial independent research funding, provided a boost in confidence, and allowed me to take my research in a new direction. Thank you for your unwavering support and friendship."
About DSA-Funded Research
Dr. Mellinghoff's lab focuses on the study of molecular pathways that regulate brain tumor growth. Their long-term goal is to develop therapeutic paradigms that target specific properties of primary brain tumors, including genetic alterations in cancer signaling pathways, unique aspects of brain tumor metabolism, or interactions of brain tumor cells with their brain microenvironment. The studies in experimental brain tumor models are closely linked to the evaluation of novel agents in early-phase clinical trials.
Neuro-Oncologist and Internist, MSKCC
Chair, Department of Neurology, MSKCC
Chief, Brain Tumor Service, MSKCC
Evnin Family Chair in Neuro-Oncology, MSKCC
Technical University, Munich Germany, M.D.
University of Munich, Internship, Internal Medicine
University of California, Los Angeles, Residency, Internal Medicine
University of California, Los Angeles, Fellowship, Hematology-Oncology
University of California, Los Angeles, Postdoctoral Fellow